Jan 6, 2022

Pfizer and BioNTech Team Up to Develop the First mRNA-Based Shingles Vaccine

Posted by in category: biotech/medical

It affects one in three people in the U.S.

After co-developing the world’s first mRNA vaccine to combat COVID-19 and providing humanity with a game-changing tool to help address the most devastating pandemic in a century, Pfizer Inc. and BioNTech SE are teaming up once more to create a vaccine using the same technology for shingles, also known as herpes zoster, which is a debilitating and painful disease that affects about one in every three people in the United States.

An … See more.

Comments are closed.